Villain M, Nordmann JP, Renard JP, Bron A, Delcourt C, Pinchinat S, Solesse De Gendre A, Pelen F. The French glaucoma and ocular hypertension 1-day study. J Fr Ophtalmol. 2006;29(5):520-5.
Villain M, Nordmann JP, Renard JP, Bron A, Delcourt C, Pinchinat S, Solesse De Gendre A, Pelen F.Montpellier
PURPOSE: The purpose of this study was to describe the distribution and
characteristics (age, duration, type, treatment, etc.) of ocular hypertension
and glaucoma in French ophthalmologic practices. METHODS: The French glaucoma
and ocular hypertension 1-day study is a descriptive cross-sectional "1-day"
type survey, conducted among all ophthalmologists of mainland France.
They had to include all patients aged 18 years and over with ocular hypertension
or glaucoma who were seen on November 25th 2003. The participation rate
was 24.0% (1.173 ophthalmologists). Among the 3.919 patients included,
3.896 subjects (99%) had usable data for the statistical analyses. RESULTS:
The ophthalmologists reported treating 16 patients with ocular hypertension
or glaucoma on average per week. Among the patients, 29.5% had ocular
hypertension, 61.7% had open-angle glaucoma, 3.4% had normal tension glaucoma,
and 5.5% angle-closure glaucoma. The ophthalmologists used surgery or
laser treatment for 74.1% of angle-closure glaucoma, while for other pathologies,
treatment with drugs only was preponderant. More than 87% of patients
received one or several ocular treatments: beta-blockers (59.3%), prostaglandins
(50.1%), carbonic anhydrase inhibitors (21.6%), or mydriatic sympathomimetics
(6.3%). CONCLUSIONS: The characteristics of glaucoma and ocular hypertension
(type of glaucoma, age, duration, etc.) correspond to those of other Western
populations. The therapeutic habits of French ophthalmologists is in line
with current international guidelines.